Literature DB >> 25582788

Preliminary findings suggest the number and volume of supragranular and infragranular pyramidal neurons are similar in the anterior superior temporal area of control subjects and subjects with autism.

Esther Kim1, Jasmin Camacho1, Zachary Combs1, Jeanelle Ariza2, Mirna Lechpammer3, Stephen C Noctor4, Verónica Martínez-Cerdeño5.   

Abstract

We investigated the cytoarchitecture of the anterior superior temporal area (TA2) of the postmortem cerebral cortex in 9 subjects with autism and 9 age-matched typically developing subjects between the ages of 13 and 56 years. The superior temporal gyrus is involved in auditory processing and social cognition and its pathology has been correlated with autism. We quantified the number and soma volume of pyramidal neurons in the supragranular layers and pyramidal neurons in the infragranular layers in each subject. We did not find significant differences in the number or volume of supragranular or infragranular neurons in the cerebral cortex of subjects with autism compared to typically developing subjects. This report does not support an alteration of supragranular to infragranular neurons in autism. However, further stereological analysis of the number of cells and cell volumes in specific cortical areas is needed to better establish the cellular phenotype of the autistic cerebral cortex and to understand its clinical relevance in autism.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Autism; Human; Postmortem; Pyramidal neurons; Superior temporal cortex

Mesh:

Year:  2015        PMID: 25582788      PMCID: PMC4336808          DOI: 10.1016/j.neulet.2015.01.021

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  33 in total

1.  Neuron number and size in prefrontal cortex of children with autism.

Authors:  Eric Courchesne; Peter R Mouton; Michael E Calhoun; Katerina Semendeferi; Clelia Ahrens-Barbeau; Melodie J Hallet; Cynthia Carter Barnes; Karen Pierce
Journal:  JAMA       Date:  2011-11-09       Impact factor: 56.272

2.  Enlarged right superior temporal gyrus in children and adolescents with autism.

Authors:  Roger J Jou; Nancy J Minshew; Matcheri S Keshavan; Matthew P Vitale; Antonio Y Hardan
Journal:  Brain Res       Date:  2010-09-09       Impact factor: 3.252

3.  Decreased somal size of deep layer 3 pyramidal neurons in the prefrontal cortex of subjects with schizophrenia.

Authors:  J N Pierri; C L Volk; S Auh; A Sampson; D A Lewis
Journal:  Arch Gen Psychiatry       Date:  2001-05

4.  Morphometric changes in early- and late-life major depressive disorder: evidence from postmortem studies.

Authors:  Ahmad A Khundakar; Alan J Thomas
Journal:  Int Psychogeriatr       Date:  2009-06-22       Impact factor: 3.878

5.  Purkinje cell size is reduced in cerebellum of patients with autism.

Authors:  S Hossein Fatemi; Amy R Halt; George Realmuto; Julie Earle; David A Kist; Paul Thuras; Amelia Merz
Journal:  Cell Mol Neurobiol       Date:  2002-04       Impact factor: 5.046

6.  Morphometric analysis of neuronal and glial cell pathology in the dorsolateral prefrontal cortex in late-life depression.

Authors:  Ahmad Khundakar; Christopher Morris; Arthur Oakley; William McMeekin; Alan J Thomas
Journal:  Br J Psychiatry       Date:  2009-08       Impact factor: 9.319

7.  Maternal autoantibodies are associated with abnormal brain enlargement in a subgroup of children with autism spectrum disorder.

Authors:  Christine Wu Nordahl; Daniel Braunschweig; Ana-Maria Iosif; Aaron Lee; Sally Rogers; Paul Ashwood; David G Amaral; Judy Van de Water
Journal:  Brain Behav Immun       Date:  2013-02-08       Impact factor: 7.217

8.  Density of cerebellar basket and stellate cells in autism: evidence for a late developmental loss of Purkinje cells.

Authors:  Elizabeth R Whitney; Thomas L Kemper; Douglas L Rosene; Margaret L Bauman; Gene J Blatt
Journal:  J Neurosci Res       Date:  2009-08-01       Impact factor: 4.164

9.  Depletion of MAP2 expression and laminar cytoarchitectonic changes in dorsolateral prefrontal cortex in adult autistic individuals.

Authors:  E B Mukaetova-Ladinska; H Arnold; E Jaros; R Perry; E Perry
Journal:  Neuropathol Appl Neurobiol       Date:  2004-12       Impact factor: 8.090

10.  Neuropathology of the posteroinferior occipitotemporal gyrus in children with autism.

Authors:  Neha Uppal; Isabella Gianatiempo; Bridget Wicinski; James Schmeidler; Helmut Heinsen; Christoph Schmitz; Joseph D Buxbaum; Patrick R Hof
Journal:  Mol Autism       Date:  2014-02-24       Impact factor: 7.509

View more
  5 in total

Review 1.  Dendrite and spine modifications in autism and related neurodevelopmental disorders in patients and animal models.

Authors:  Verónica Martínez-Cerdeño
Journal:  Dev Neurobiol       Date:  2016-08-30       Impact factor: 3.964

2.  The Number of Parvalbumin-Expressing Interneurons Is Decreased in the Prefrontal Cortex in Autism.

Authors:  Ezzat Hashemi; Jeanelle Ariza; Haille Rogers; Stephen C Noctor; Verónica Martínez-Cerdeño
Journal:  Cereb Cortex       Date:  2017-03-01       Impact factor: 5.357

Review 3.  Autism spectrum disorder: neuropathology and animal models.

Authors:  Merina Varghese; Neha Keshav; Sarah Jacot-Descombes; Tahia Warda; Bridget Wicinski; Dara L Dickstein; Hala Harony-Nicolas; Silvia De Rubeis; Elodie Drapeau; Joseph D Buxbaum; Patrick R Hof
Journal:  Acta Neuropathol       Date:  2017-06-05       Impact factor: 17.088

4.  Exposure to DMSO during infancy alters neurochemistry, social interactions, and brain morphology in long-evans rats.

Authors:  Zachary Rabow; Taryn Morningstar; Megan Showalter; Hailey Heil; Krista Thongphanh; Sili Fan; Joanne Chan; Verónica Martínez-Cerdeño; Robert Berman; David Zagzag; Evgeny Nudler; Oliver Fiehn; Mirna Lechpammer
Journal:  Brain Behav       Date:  2021-04-10       Impact factor: 2.708

Review 5.  Toward a conceptual framework for early brain and behavior development in autism.

Authors:  J Piven; J T Elison; M J Zylka
Journal:  Mol Psychiatry       Date:  2017-07-25       Impact factor: 15.992

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.